The House approved health-care legislation aimed at slashing drug costs and rolling back President Trump's changes to the 2010 health law, as Democrats sought to turn a winning midterm message into a 2020-election weapon. But the bill has no chance of advancing in the Senate, because of Republican complaints that Obamacare-related "poison pills" had eclipsed bipartisan work on prescription drugs.
May 16, 2019